Delivery Order SPE2DR25D3401-SPE2DR26FL0SF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,152.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine syringes (0.25mL formulation for ages 6-11 years), with a completion deadline of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical supply vehicle valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,152.65 to supply SPIKEVAX 2025-26 vaccine syringes (0.25ml for ages 6-11 years) with a completion date of November 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,413.71 delivery order to AmerisourceBergen Drug Corp on December 6, 2025, for Spikevax 2025-26 vaccine doses (0.25mL syringes for ages 6-11 years) with completion by December 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.02 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed price, non-set-aside delivery order was awarded on November 17, 2025, with an ultimate completion date of December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.20 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (12 years and older) vaccine syringes, 0.5mL, with an ultimate completion date of December 17, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the prime contractor based in Conshohocken, Pennsylvania. The award supports federal medical procurement needs, with performance to be delivered at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a $7,227.30 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5mL syringes, with an ultimate completion date of September 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,152.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 (6M-11Y) syringes at 0.25mL, with a completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric COVID-19 vaccine supply for the federal medical supply chain. The award is issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0SFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,156.93 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine syringes (0.25mL dosage for ages 6-11 years). This is a firm fixed price delivery order with an ultimate completion date of January 8, 2026, and was awarded competitively with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies critical medical commodities including vaccines, specialty medications, and generic drugs to support military healthcare systems and other federal customers including the Defense Health Agency and U.S. Coast Guard. The company's status as a major pharmaceutical distributor headquartered in Pennsylvania positions it as a critical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/15/25 |